framycetin has been researched along with sb 203580 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, EM; Chattopadhyay, N; Kifor, O; Sanders, JL; Yamaguchi, T | 1 |
| Kalsi, KK; Kochan, Z; Lawson, C; McCormack, A; Smolenski, RT; Yacoub, MH | 1 |
2 other study(ies) available for framycetin and sb 203580
| Article | Year |
|---|---|
Activation of p42/44 and p38 mitogen-activated protein kinases by extracellular calcium-sensing receptor agonists induces mitogenic responses in the mouse osteoblastic MC3T3-E1 cell line.
Topics: 3T3 Cells; Animals; Calcium; Cell Division; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Gadolinium; Imidazoles; JNK Mitogen-Activated Protein Kinases; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Neomycin; Osteoblasts; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Receptors, Calcium-Sensing; Receptors, Cell Surface; Spermine | 2000 |
TNF-alpha reduces the activity of ecto-5'-nucleotidase in human endothelial cells.
Topics: 5'-Nucleotidase; Cells, Cultured; Endothelium, Vascular; Flavonoids; Humans; Imidazoles; Neomycin; Pyridines; Tumor Necrosis Factor-alpha; Type C Phospholipases | 2000 |